ClinicalTrials.Veeva

Menu

Effect of Capacitive and Resistive Radiofrequency on Postpartum Diastasis Recti

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Diastasis Recti Abdominis (DRA)
Radiofrequency

Treatments

Device: abdominal belt
Device: TECAR therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06909448
radiofrequency on diastasis

Details and patient eligibility

About

To evaluate the effect of capacitive and resistive radiofrequency on postpartum rectus abdominis diastasis.

Full description

Eighty females postpartum with rectus diastasis will be included in this study; they will be recruited the outpatient clinic at El Mahalla Al Kobra (The first author's pervious workplace) and will be referred by obstetric and genecology physicians. Patients will be assigned into two groups.

Group A: It will include 40 patients participating in abdominal belt. Group B: It will include 40 patients participating in abdominal belt plus TECAR therapy.

Enrollment

80 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Postpartum women (7 days after delivery) having diastasis recti (separation between the two recti more than 2.5cm at the level of umbilicus).

    2. Multiparous women (2-3) times delivered vaginally with or without episiotomy.

    3. Their age will be ranged from 20 -35 years old. 4. Their BMI will be less than 30 kg/cm2.

Exclusion criteria

  • Any participant will be excluded if she meets one or more of the following criteria:

Postpartum women will be excluded from the study if they have:

  1. Abdominal or back surgery.
  2. Abdominal hernia.
  3. History of abnormal pregnancy, uterine fibroid or polyhydramnios during pregnancy.
  4. Neurological disorders as multiple sclerosis, stroke and spinal lesion.
  5. Musculoskeletal diseases such as fractures muscle strains, severe knee osteoarthritis which may affect their physical activity.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

control group
Active Comparator group
Description:
It will be consisted of 40 postpartum women who will only wear abdominal belt for 14 weeks.
Treatment:
Device: abdominal belt
study group
Active Comparator group
Description:
will wear the same abdominal belt for 6 weeks then participating in TECAR therapy 3 sessions /week for 8 weeks.
Treatment:
Device: TECAR therapy
Device: abdominal belt

Trial contacts and locations

0

Loading...

Central trial contact

Mohamed Gamil Omar, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems